63 related articles for article (PubMed ID: 23161034)
1. Elevated uric acid and functional mitral regurgitation in dilated cardiomyopathy.
Yazicioğlu MV; Avci A; Açar G; Esen Ö; Karaca O; Alici G; Özkan B; Alizade E; Bulut M; Akçakoyun M; Esen AM
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1637-41. PubMed ID: 23161034
[TBL] [Abstract][Full Text] [Related]
2. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
[TBL] [Abstract][Full Text] [Related]
3. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.
De Bonis M; Lapenna E; Verzini A; La Canna G; Grimaldi A; Torracca L; Maisano F; Alfieri O
Ann Thorac Surg; 2008 Mar; 85(3):932-9. PubMed ID: 18291174
[TBL] [Abstract][Full Text] [Related]
5. The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy.
Tigen K; Karaahmet T; Kirma C; Kilicgedik A; Dundar C; Pala S; Cevik C; Guler A; Gurel E; Basaran Y
Cardiol J; 2010; 17(3):274-80. PubMed ID: 20535718
[TBL] [Abstract][Full Text] [Related]
6. Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation.
Mayer SA; De Lemos JA; Murphy SA; Brooks S; Roberts BJ; Grayburn PA
Am J Cardiol; 2004 Apr; 93(8):1002-6. PubMed ID: 15081443
[TBL] [Abstract][Full Text] [Related]
7. Mitral valve surgery for mitral regurgitation in patients with advanced dilated cardiomyopathy.
Gatti G; Cardu G; Pugliese P
Ital Heart J; 2003 Jan; 4(1):29-34. PubMed ID: 12690918
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
[TBL] [Abstract][Full Text] [Related]
9. Serum carbohydrate antigen 125 levels in nonischemic dilated cardiomyopathy: a useful biomarker for prognosis and functional mitral regurgitation.
Karaca O; Guler GB; Guler E; Gunes HM; Alizade E; Agus HZ; Gol G; Kahveci G; Esen O; Esen AM; Turkmen M
Congest Heart Fail; 2012; 18(3):144-50. PubMed ID: 22587744
[TBL] [Abstract][Full Text] [Related]
10. Tenting area reflects disease severity and prognosis in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation.
Karaca O; Avci A; Guler GB; Alizade E; Guler E; Gecmen C; Emiroglu Y; Esen O; Esen AM
Eur J Heart Fail; 2011 Mar; 13(3):284-91. PubMed ID: 21106544
[TBL] [Abstract][Full Text] [Related]
11. High levels of high-sensitivity C-reactive protein and uric acid can predict disease severity in patients with mitral regurgitation.
Turker Y; Ekinozu I; Turker Y; Akkaya M
Rev Port Cardiol; 2014 Nov; 33(11):699-706. PubMed ID: 25448796
[TBL] [Abstract][Full Text] [Related]
12. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation.
Detaint D; Messika-Zeitoun D; Chen HH; Rossi A; Avierinos JF; Scott C; Burnett JC; Enriquez-Sarano M
Am J Cardiol; 2006 Apr; 97(7):1029-34. PubMed ID: 16563910
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum uric acid levels impair coronary microvascular function in patients with idiopathic dilated cardiomyopathy.
Gullu H; Erdogan D; Caliskan M; Tok D; Kulaksizoglu S; Yildirir A; Muderrisoglu H
Eur J Heart Fail; 2007 May; 9(5):466-8. PubMed ID: 17169608
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering.
Lee AP; Acker M; Kubo SH; Bolling SF; Park SW; Bruce CJ; Oh JK
Circulation; 2009 May; 119(19):2606-14. PubMed ID: 19414639
[TBL] [Abstract][Full Text] [Related]
16. Myocardial velocity gradient reflects the severity of myocardial damage regardless of the presence or absence of mitral regurgitation.
Shimizu Y; Uematsu M; Nagaya N; Yamagishi M; Yamamoto H; Miyatake K; Imazu M; Kohno N
J Am Soc Echocardiogr; 2003 Mar; 16(3):246-53. PubMed ID: 12618733
[TBL] [Abstract][Full Text] [Related]
17. Mitral effective regurgitant orifice area versus left ventricular ejection fraction as prognostic indicators in patients with dilated cardiomyopathy and heart failure.
Venturi F; Gianfaldoni ML; Melina G; Cecchi A; Petix NR; Monopoli A; Taiti A; Mazzoni V; Fantini F
Ital Heart J; 2004 Oct; 5(10):755-61. PubMed ID: 15626272
[TBL] [Abstract][Full Text] [Related]
18. Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS.
D'Andrea A; Caso P; Cuomo S; Scarafile R; Salerno G; Limongelli G; Di Salvo G; Severino S; Ascione L; Calabrò P; Romano M; Romano G; Santangelo L; Maiello C; Cotrufo M; Calabrò R
Eur Heart J; 2007 Apr; 28(8):1004-11. PubMed ID: 17400608
[TBL] [Abstract][Full Text] [Related]
19. Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
Konstantinou DM; Papadopoulou K; Giannakoulas G; Kamperidis V; Dalamanga EG; Damvopoulou E; Parcharidou DG; Karamitsos TD; Karvounis HI
Echocardiography; 2014; 31(1):21-8. PubMed ID: 23930844
[TBL] [Abstract][Full Text] [Related]
20. The role of B-type natriuretic peptide in the evaluation of left atrioventricular valve regurgitation following surgical repair of partial atrioventricular canal.
Wójcik A; Klisiewicz A; Szymański P; Janas J; Różański J; Kuśmierczyk M; Hoffman P
Kardiol Pol; 2012; 70(5):464-70. PubMed ID: 22623236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
